Possible new target for sickle cell disease and beta thalassemia treatment identified
Harvard Medical School researchers at Boston Children's Hospital and Dana-Farber Cancer Institute have identified a new pathway that regulates the production of fetal hemoglobin, a form of hemoglobin that normally gets replaced soon after birth by adult hemoglobin.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Newly discovered cell type helps shape blood vessel growth in the heart
United Kingdom
-
Herpesvirus eye infections show distinct patterns linked to immune status
United Kingdom
-
Gut bacterial compound worsens brain injury after stroke, study suggests
United Kingdom
-
Breweries adapt as tastes in beer change
United States
-
New research reveals why modern display colors can look different to different people
United Kingdom
-
Time and space may help caregivers shift from expressing emotions to exploring solutions
United Kingdom
-
GLP-1 prescriptions for new mothers have increased sharply
United Kingdom
-
Matching infrared wavelengths to skin improves local blood circulation in small human trial
United Kingdom